Responses
Clinical and epidemiological research
Extended report
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries
Compose a Response to This Article
Other responses
No responses have been published for this article.